They were formed to provide greater access to healthcare and lower costs, but they may be doing more harm than good.
Politics and Policy
How the president’s Advancing American Kidney Health’ Initiative will impact policy.
A proposed policy calling for hospitals to publicly disclose negotiated prices charged for services is drawing ire from some hospitals and insurance companies.
Healthcare experts weigh in on what we can expect in 2019 and beyond.
While the government shutdown doesn’t directly affect HHS, the shutdown is having profound and long-lasting effects on the U.S. healthcare system.
Four things you need to know about the Trump Administration’s proposed regs.
The much-anticipated 2018 midterm elections are over, but the effects on healthcare are lasting. What’s next?
Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
About half of states have transitioned at least some Medicaid beneficiaries away from fee-for-service (FFS) drug programs into drug plans integrated with managed care. Our policy analyst shares why he believes more should do so.
How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.